Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Julio Badie

Showing results (11-20 of 47) with videos related to

Pageof 5
Sort By:
Microbes and Infection|June 24, 2020
Predictive factors of mortality in patients treated with tocilizumab for acute respiratory distress syndrome related to coronavirus disease 2019 (COVID-19)Anne Lohse, Timothée Klopfenstein, Jean-Charles Balblanc, et al.
Contemporary Clinical Trials|July 2, 2019
Effect of fluid balance control in critically ill patients: Design of the stepped wedge trial POINCARE-2Nelly Agrinier, Alexandra Monnier, Laurent Argaud, et al.
Infectious Diseases and Therapy|July 11, 2021
Systematic Review and Subgroup Meta-analysis of Randomized Trials to Determine Tocilizumab's Place in COVID-19 PneumoniaTimothée Klopfenstein, Vincent Gendrin, Aurélie Gerazime, et al.
Critical Care (London, England)|April 5, 2022
Continuous renal replacement therapy versus intermittent hemodialysis as first modality for renal replacement therapy in severe acute kidney injury: a secondary analysis of AKIKI and IDEAL-ICU studiesStéphane Gaudry, François Grolleau, Saber Barbar, et al.
Critical Care (London, England)|April 9, 2013
The epidemiology of septic shock in French intensive care units: the prospective multicenter cohort EPISS studyJean-Pierre Quenot, Christine Binquet, Fady Kara, et al.
The New England Journal of Medicine|March 12, 2020
Liberal or Conservative Oxygen Therapy for Acute Respiratory Distress SyndromeLoic Barrot, Pierre Asfar, Frederic Mauny, et al.
Critical Care (London, England)|February 22, 2023
Fluid balance control in critically ill patients: results from POINCARE-2 stepped wedge cluster-randomized trialPierre-Edouard Bollaert, Alexandra Monnier, Francis Schneider, et al.
Critical Care Medicine|August 22, 2013
Profile of the risk of death after septic shock in the present era: an epidemiologic studyArnaud Pavon, Christine Binquet, Fady Kara, et al.
Clinical and Experimental Rheumatology|June 24, 2020
Biomarker variation in patients successfully treated with tocilizumab for severe coronavirus disease 2019 (COVID-19): results of a multidisciplinary collaborationThierry Conrozier, Anne Lohse, Jean-Charles Balblanc, et al.
Annals of Intensive Care|July 3, 2019
Trisodium citrate 4% versus heparin as a catheter lock for non-tunneled hemodialysis catheters in critically ill patients: a multicenter, randomized clinical trialJean-Pierre Quenot, Julie Helms, Abderrahmane Bourredjem, et al.
Pageof 5

Showing results (11-20 of 47) with videos related to

Sort By:
Pageof 5
Microbes and Infection|June 24, 2020
Predictive factors of mortality in patients treated with tocilizumab for acute respiratory distress syndrome related to coronavirus disease 2019 (COVID-19)Anne Lohse, Timothée Klopfenstein, Jean-Charles Balblanc, et al.
Contemporary Clinical Trials|July 2, 2019
Effect of fluid balance control in critically ill patients: Design of the stepped wedge trial POINCARE-2Nelly Agrinier, Alexandra Monnier, Laurent Argaud, et al.
Infectious Diseases and Therapy|July 11, 2021
Systematic Review and Subgroup Meta-analysis of Randomized Trials to Determine Tocilizumab's Place in COVID-19 PneumoniaTimothée Klopfenstein, Vincent Gendrin, Aurélie Gerazime, et al.
Critical Care (London, England)|April 5, 2022
Continuous renal replacement therapy versus intermittent hemodialysis as first modality for renal replacement therapy in severe acute kidney injury: a secondary analysis of AKIKI and IDEAL-ICU studiesStéphane Gaudry, François Grolleau, Saber Barbar, et al.
Critical Care (London, England)|April 9, 2013
The epidemiology of septic shock in French intensive care units: the prospective multicenter cohort EPISS studyJean-Pierre Quenot, Christine Binquet, Fady Kara, et al.
The New England Journal of Medicine|March 12, 2020
Liberal or Conservative Oxygen Therapy for Acute Respiratory Distress SyndromeLoic Barrot, Pierre Asfar, Frederic Mauny, et al.
Critical Care (London, England)|February 22, 2023
Fluid balance control in critically ill patients: results from POINCARE-2 stepped wedge cluster-randomized trialPierre-Edouard Bollaert, Alexandra Monnier, Francis Schneider, et al.
Critical Care Medicine|August 22, 2013
Profile of the risk of death after septic shock in the present era: an epidemiologic studyArnaud Pavon, Christine Binquet, Fady Kara, et al.
Clinical and Experimental Rheumatology|June 24, 2020
Biomarker variation in patients successfully treated with tocilizumab for severe coronavirus disease 2019 (COVID-19): results of a multidisciplinary collaborationThierry Conrozier, Anne Lohse, Jean-Charles Balblanc, et al.
Annals of Intensive Care|July 3, 2019
Trisodium citrate 4% versus heparin as a catheter lock for non-tunneled hemodialysis catheters in critically ill patients: a multicenter, randomized clinical trialJean-Pierre Quenot, Julie Helms, Abderrahmane Bourredjem, et al.
Pageof 5